Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | 225Ac-FPI-1966 |
| Trade Name | |
| Synonyms | 225Ac-Vofatamab|[225Ac]-FPI-1966|actinium-225 vofatamab |
| Drug Descriptions |
225Ac-FPI-1966 is a radioconjugate comprising vofatamab, a monoclonal antibody that targets FGFR3, linked to the radionuclide Actinium-225, which delivers radiation to tumor cells, potentially resulting in cytotoxic effects (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C187702 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| 225Ac-FPI-1966 | 225Ac-FPI-1966 | 0 | 0 |
| 225Ac-FPI-1966 + Vofatamab | 225Ac-FPI-1966 Vofatamab | 0 | 1 |